Welcome to our dedicated page for Taylor Morrison Home SEC filings (Ticker: TMHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Taylor Morrison Home Corporation filings document formal disclosures for a NYSE-listed national homebuilder and land developer. Recent 8-K reports furnish operating results and financial condition updates, including home closings, orders, margins, backlog and related exhibits furnished with earnings releases.
The company’s regulatory filings also cover proxy governance for annual meeting matters, director elections, executive compensation votes, board and committee composition, material credit agreements, subsidiary senior unsecured notes, tender offers and the registered common stock structure.
Taylor Morrison Home Corporation reported third‑quarter results. Total revenue was $2,095,751,000, essentially flat year over year, and net income was $201,441,000 with diluted EPS of $2.01. Gross margin was $476,621,000.
Year to date, revenue reached $6,021,840,000 and net income was $608,484,000. The company recorded inventory impairment charges of $7.2 million in Q3 and $28.8 million for the nine months, primarily in the East and West segments. Financial Services contributed revenue of $55,918,000 in Q3.
Cash from operating activities was $170,914,000 for the nine months. Cash and cash equivalents were $370,591,000, with no borrowings outstanding on the $1.0 billion revolver. Total debt carried was $2,190,761,000 including senior notes and project‑level borrowings. The company repurchased 1,277,533 shares in Q3 for $74,553,000, leaving $600,447,000 authorized for future repurchases. Shares outstanding were 97,725,037 as of October 22, 2025.
Taylor Morrison Home Corporation furnished an update on its recent performance by submitting a Form 8-K related to quarterly results. The company reported that it issued a press release detailing its financial results for the third quarter ended September 30, 2025, and attached that release as Exhibit 99.1. The press release is provided for information purposes and is designated as "furnished" rather than "filed," which limits its use in certain legal and regulatory contexts.
Christopher J. Yip, a director of Taylor Morrison Home Corp (TMHC), had 6,158 deferred stock units vest on 09/02/2025. Each unit converts into one share of common stock, and the units were granted under the company’s Non-Employee Director Deferred Compensation Plan that allows directors to defer cash retainers and committee fees. Following the vesting and conversion, Mr. Yip beneficially owns 8,866 shares of common stock, reported as direct ownership. The filing reports the acquisition via Code M and indicates the units were treated as non-derivative shares when converted.
Taylor Morrison Home Corporation reported that Board member Fletcher Previn resigned from the Board of Directors effective September 14, 2025, citing other commitments. The company states that his resignation was not due to any disagreement regarding its operations, policies, or practices.
Following his departure, the Board approved a reduction in its size from nine members to eight members, rather than appointing an immediate replacement. The filing emphasizes a smooth transition and expresses well wishes to Mr. Previn for his future endeavors.
Taylor Morrison Home Corp insider Todd Merrill reported a sale of 4,412 shares of TMHC common stock on 09/12/2025 at a price of $70.04 per share. The Form 4 shows 0 shares beneficially owned by the reporting person following the transaction. The filing is signed and dated 09/15/2025.
Anne L. Mariucci, a director of Taylor Morrison Home Corp (TMHC), reported a sale of common stock on 09/11/2025. The filing shows 14,002 shares were disposed of at a price of $70 per share. After the transaction she is reported to beneficially own 48,191 shares directly and 10,917 shares indirectly via the Anne Mariucci Family Trust.
Taylor Morrison Home Corp (TMHC) Form 144 notice: An affiliate proposes to sell 4,412 common shares on 09/12/2025 through Fidelity Brokerage Services (NYSE). The disclosed aggregate market value of the proposed sale is $309,016.48 against 98,843,205 shares outstanding. The shares reported were acquired by restricted stock vesting on 02/11/2025 (3,310 shares), 02/21/2025 (670 shares) and 02/23/2025 (432 shares) and were paid as compensation. The filer reports no other sales in the past three months and includes the standard attestation regarding material nonpublic information.
The filer submitted a Form 144 notice proposing the sale of 14,002 shares of common stock of Taylor Morrison Home Corporation (TMHC) through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $980,140 and total shares outstanding reported as 98,843,205. The proposed approximate sale date is 09/11/2025. The shares were acquired in two employer-related transactions: 9,960 shares from a stock option exercise on 06/15/2023 (paid in cash) and 4,042 shares from restricted stock vesting on 05/23/2024 (compensation). The filer reported no securities sold in the past three months and included the standard representation that they do not possess undisclosed material adverse information.
Sheryl D. Palmer, Chairman, President and CEO of Taylor Morrison Home Corp (TMHC), sold 13,513 shares of TMHC common stock on 09/05/2025 at a weighted average price of $72.06 under a pre-established Rule 10b5-1 plan. After the reported sale, Ms. Palmer directly beneficially owned 370,475 shares and indirectly held 19,211 shares through the Sheryl D. Palmer Trust. The filing states the 10b5-1 plan was entered March 19, 2025, and that the reported sale comprised multiple transactions at prices ranging from $72.00 to $72.39. The Form 4 was signed by an attorney-in-fact on 09/08/2025.
Curtis Vanhyfte, Chief Financial Officer of Taylor Morrison Home Corporation (TMHC), reported option exercise and an offsetting sale on 08/22/2025. He exercised 5,082 employee stock options at an exercise price of $29.08 per share and immediately sold 5,082 common shares at $69.97 per share.
After these transactions, Mr. Vanhyfte beneficially owned 11,742 common shares and continued to hold 3,081 employee stock options. The filing notes that of the original option grant, 2,001 options vested on February 11, 2024 and 3,081 vested on February 11, 2025. The Form 4 was signed by an attorney-in-fact on 08/26/2025.